Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is challenging to diagnose because of nonspecific findings, particularly in the early phases of the disease. Clinical diagnosis is made on the basis of several criteria, but these lack sensitivity. Asimaki et al. suggest that immunohistochemical analysis of myocardial desmosomal proteins is a highly sensitive and specific diagnostic test for ARVD/C.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Profiling of differentially expressed microRNAs in arrhythmogenic right ventricular cardiomyopathy
Scientific Reports Open Access 16 June 2016
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Marcus, F. I. et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation 65, 384–398 (1982).
McKenna, W. J. et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br. Heart J. 71, 215–218 (1994).
Asimaki, A. et al. A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N. Engl. J. Med. 360, 1075–1084 (2009).
Rampazzo, A. et al. Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am. J. Hum. Genet. 71, 1200–1206 (2002).
Gerull, B. et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat. Genet. 36, 1162–1164 (2004).
Dalal, D. et al. Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. Circulation 113, 1641–1649 (2006).
van Tintelen, J. P. et al. Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 113, 1650–1658 (2006).
Sen-Chowdhry, S., Syrris, P. & McKenna, W. J. Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J. Am. Coll. Cardiol. 50, 1813–1821 (2007).
Marcus, F. I. et al. Arrhythmogenic right ventricular cardiomyopathy/dysplasia, clinical presentation and diagnostic evaluation: results from the North American multidisciplinary study. Heart Rhythm doi:10.1016/j.hrthm.2009.03.013.
van Tintelen, J. P. et al. Molecular genetics of arrhythmogenic right ventricular cardiomyopathy: emerging horizon? Curr. Opin. Cardiol. 22, 185–192 (2007).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
van Tintelen, J., Hauer, R. New test for arrhythmogenic right ventricular cardiomyopathy. Nat Rev Cardiol 6, 450–451 (2009). https://doi.org/10.1038/nrcardio.2009.97
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2009.97
This article is cited by
-
Profiling of differentially expressed microRNAs in arrhythmogenic right ventricular cardiomyopathy
Scientific Reports (2016)